共 21 条
- [1] CIMETIDINE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN PEPTIC-ULCER DISEASE[J]. DRUGS, 1978, 15 (02) : 93 - 131BROGDEN, RNHEEL, RCSPEIGHT, TMAVERY, GS
- [2] CONTRIBUTION OF INDIVIDUAL-DIFFERENCES IN GASTRIC-EMPTYING TO VARIABILITY IN PLASMA PROPRANOLOL CONCENTRATIONS[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (02) : 121 - 122CASTLEDEN, CMGEORGE, CFSHORT, MD
- [3] CIMETIDINE IMPAIRS ELIMINATION OF CHLORDIAZEPOXIDE (LIBRIUM) IN MAN[J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (02) : 266 - 268DESMOND, PVPATWARDHAN, RVSCHENKER, SSPEEG, KV
- [4] DONOVAN MA, 1981, LANCET, V1, P164
- [5] REDUCTION OF LIVER BLOOD-FLOW AND PROPRANOLOL METABOLISM BY CIMETIDINE[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (12) : 692 - 695FEELY, JWILKINSON, GRWOOD, AJJ
- [6] GARDNER SK, 1980, INT J CLIN PHARM TH, V18, P421
- [7] GRABOWSKI BS, 1980, INT J CLIN PHARM TH, V18, P317
- [8] DELAYED CLEARANCE OF DIAZEPAM DUE TO CIMETIDINE[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (18) : 1012 - 1014KLOTZ, UREIMANN, I
- [9] INFLUENCE OF CIMETIDINE ON THE PHARMACOKINETICS OF DESMETHYLDIAZEPAM AND OXAZEPAM[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (06) : 517 - 520KLOTZ, UREIMANN, I
- [10] BIOAVAILABILITY OF SUSTAINED-RELEASE PROPRANOLOL FORMULATIONS[J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (01) : 39 - 48MCAINSH, JBABER, NSHOLMES, BFYOUNG, JELLIS, SH